Sortiert nach PI

Publikationen - sortiert nach Principle Investigator

• Vanicek T, Unterholzner J, Lanzenberger R, Naderi-Heiden A, Kasper S, Praschak-Rieder N (2022) Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder World J Biol Psychiatry, 23 (9): 715-718
  | Weblink |

• Hahn A, Reed M, Pichler V, Michenthaler P, Rischka L, Godbersen G, Wadsak W, Hacker M, Lanzenberger R (2021) Functional dynamics of dopamine synthesis during monetary reward and punishment processing Cereb Blood Flow Metab, : 0271678X2110198
• Rischka L, Godbersen G, Pichler V, Michenthaler P, Klug S, Klöbl M, Ritter V, Wadsak W, Hacker M, Kasper S, Lanzenberger R, Hahn A (2021) Reliability of task-specific neuronal activation assessed with functional PET, ASL and BOLD imaging Cereb Blood Flow Metab, : 0271678X2110205
  | Weblink |
• Höflich A, Kraus C, Pfeiffer R, Seiger R, Rujescu D, Zarate C, Kasper S, Winkler D, Lanzenberger R (2021) Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial Transl Psychiat, 11 (1): 200
  | Weblink |
• Seiger R, Gryglewski G, Klöbl M, Kautzky A, Godbersen G, Rischka L, Vanicek T, Hienert M, Unterholzner J, Silberbauer L, Michenthaler P, Handschuh P, Hahn A, Kasper S, Lanzenberger R (2021) The influence of acute SSRI administration on white matter microstructure in patients suffering from major depressive disorder and healthy controls Int J Neuropsychopharmacol, 24 (7): 542-550
  | Weblink |

• Kraus C, Hahn A, Sigurdardottir H, Spurny B, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R (2020) Brain glucose uptake during transcranial direct current stimulation measured with functional [18F]FDG-PET Brain Imaging Behav, 14 (2): 477-484
  | Weblink |
• Komorowski A, Weidenauer A, Murgaš M, Sauerzopf U, Wadsak W, Mitterhauser M, Bauer M, Hacker M, Praschak-Rieder N, Kasper S, Lanzenberger R, Willeit M (2020) Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain Neuroimage, 223: 117270
  | Weblink |
• Unterholzner J, Gryglewski G, Philippe C, Seiger R, Pichler V, Godbersen G, Berroterán-Infante N, Murgaš M, Hahn A, Wadsak W, Mitterhauser M, Kasper S, Lanzenberger R (2020) Topologically Guided Prioritization of Candidate Gene Transcripts Coexpressed with the 5-HT1A Receptor by Combining In Vivo PET and Allen Human Brain Atlas Data Cereb. Cortex, 30 (6): 3771-3780
  | Weblink |
• Kautzky A, Vanicek T, Philippe C, Kranz G, Wadsak W, Mitterhauser M, Hartmann A, Hahn A, Hacker M, Rujescu D, Kasper S, Lanzenberger R (2020) Machine learning classification of ADHD and HC by multimodal serotonergic data Transl Psychiat, 10: 104
  | Weblink |
• Silberbauer L, Bartova L, Papageorgiou K, Lanzenberger R, Kasper S, Winkler D (2020) Oral Ketamine as a Treatment Option in Patients With Treatment Resistant Depression and Comorbid Arterial Hypertension J Clin Psychopharmacol, 40 (4): 418-420
• Hahn A, Breakspear M, Rischka L, Wadsak W, Godbersen G, Pichler V, Michenthaler P, Vanicek T, Hacker M, Kasper S, Lanzenberger R, Cocchi L (2020) Reconfiguration of functional brain networks and metabolic cost converge during task performance eLife, 9: e52443
  | Weblink |
• Spurny B, Seiger R, Moser P, Vanicek T, Reed M, Heckova E, Michenthaler P, Basaran A, Gryglewski G, Klöbl M, Trattnig S, Kasper S, Bogner W, Lanzenberger R (2020) Hippocampal GABA levels correlate with retrieval performance in an associative learning paradigm Neuroimage, 204: 116244
  | Weblink |
• Klöbl M, Gryglewski G, Rischka L, Godbersen G, Unterholzner J, Reed M, Michenthaler P, Vanicek T, Winkler-Pjrek E, Hahn A, Kasper S, Lanzenberger R (2020) Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge Front Comput Neurosci, 14: 554186
  | Weblink |

• Silberbauer L, James G, Spies M, Michenthaler P, Kranz GS, Kasper S, Lanzenberger R (2020) Molecular neuroimaging of the serotonergic system with PET. In: , Handbook of the Behavioral Neurobiology of Serotonin Elsevier: 175-194

• Rütgen M, Pletti C, Tik M, Kraus C, Pfabigan D, Sladky R, Klöbl M, Woletz M, Vanicek T, Windischberger C, Lanzenberger R, Lamm C (2019) Antidepressant treatment, not depression, leads to reductions in behavioral and neural responses to pain empathy Transl Psychiat, 9 (1)
• Rischka L, Gryglewski G, Berroterán-Infante N, Rausch I, James G, Klöbl M, Sigurdardottir H, Hartenbach M, Hahn A, Wadsak W, Mitterhauser M, Beyer T, Kasper S, Prayer D, Hacker M, Lanzenberger R (2019) Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI Front Physiol, 10: 1422
  | Weblink |
• Gryglewski G, Seiger R, Baldinger-Melich P, Unterholzner J, Spurny B, Vanicek T, Hahn A, Kasper S, Frey R, Lanzenberger R (2019) Changes in White Matter Microstructure After Electroconvulsive Therapy for Treatment-Resistant Depression Int J Neuropsychopharmacol, 23 (1): 20-25
  | Weblink |
• Spies M, Klöbl M, Höflich A, Hummer A, Vanicek T, Michenthaler P, Kranz G, Hahn A, Winkler D, Windischberger C, Kasper S, Lanzenberger R (2019) Association between dynamic resting-state functional connectivity and ketamine plasma levels in visual processing networks Sci Rep, 9 (1): 11484
  | Weblink |
• Sigurdardottir H, Kranz G, Rami-Mark C, James G, Vanicek T, Gryglewski G, Berroterán-Infante N, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hartmann A, Hacker M, Rujescu D, Kasper S, Lanzenberger R (2019) Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET Mol Psychiatry,
  | Weblink |

• Komorowski A, Kautzky A, Vanicek T, Lanzenberger R, Kasper S (2019) Hirnbildgebung im forensischen Kontext – Möglichkeiten und Grenzen Journal für Neurologie, Neurochirurgie und Psychiatrie, 20: 25-33

• Kautzky A, Lanzenberger R, Kasper S (2019) Big Data Guided Interventions: Predicting Treatment Response. In: Passos IC, Mwangi B, Kapczinski F, Personalized Psychiatry - Big Data Analytics in Mental Health Springer International Publishing: 53-76
  | Weblink |

• Woletz M, Hoffmann A, Tik M, Sladky R, Lanzenberger R, Robinson S, Windischberger C (2018) Beware detrending: Optimal preprocessing pipeline for low-frequency fluctuation analysis Human Brain Mapping, 40 (5): 1571-1582
• Kraus C, Klöbl M, Tik M, Auer B, Vanicek T, Geissberger N, Pfabigan D, Hahn A, Woletz M, Paul K, Komorowski A, Kasper S, Windischberger C, Lamm C, Lanzenberger R (2018) The pulvinar nucleus and antidepressant treatment: dynamic modeling of antidepressant response and remission with ultra-high field functional MRI Mol Psychiatry, 24 (5): 746-756
  | Weblink |

• Hahn A, Gryglewski G, Nics L, Rischka L, Ganger S, Sigurdardottir H, Vraka C, Silberbauer L, Vanicek T, Kautzky A, Wadsak W, Mitterhauser M, Hartenbach M, Hacker M, Kasper S, Lanzenberger R (2017) Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity Brain Struct Funct, 223: 1369-1378
  | Weblink |

• Hahn A, Gryglewski G, Nics L, Hienert M, Rischka L, Vraka C, Sigurdardottir H, Vanicek T, James G, Seiger R, Kautzky A, Silberbauer L, Wadsak W, Mitterhauser M, Hacker M, Kasper S, Lanzenberger R (2016) Quantification of task-specific glucose metabolism with constant infusion of 18F-FDG J Nucl Med, 57 (12): 1933-1940
  | Weblink |
• Spies M, Hahn A, Kranz G, Sladky R, Kaufmann U, Hummer A, Ganger S, Kraus C, Winkler D, Seiger R, Comasco E, Windischberger C, Kasper S, Lanzenberger R (2016) Gender transition affects neural correlates of empathy: A resting state functional connectivity study with ultra high-field 7T MR imaging Neuroimage, 138: 257-265
  | Weblink |
• Hahn A, Kranz G, Sladky R, Kaufmann U, Ganger S, Hummer A, Seiger R, Spies M, Vanicek T, Winkler D, Kasper S, Windischberger C, Swaab D, Lanzenberger R (2016) Testosterone affects language areas of the adult human brain Human Brain Mapping, 37 (5): 1738-1748
  | Weblink |
• Sigurdardottir H, Kranz G, Rami-Mark C, James G, Vanicek T, Gryglewski G, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Rujescu D, Kasper S, Lanzenberger R (2016) Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET Human Brain Mapping, 37 (3): 884-895
  | Weblink |

• Ganger S, Hahn A, Küblböck M, Kranz G, Spies M, Vanicek T, Seiger R, Sladky R, Windischberger C, Kasper S, Lanzenberger R (2015) Comparison of continuously acquired resting state and extracted analogues from active tasks Human Brain Mapping, 36 (10): 4053-4063
• Rami-Mark C, Berroterán-Infante N, Philippe C, Foltin S, Vraka C, Hoepping A, Lanzenberger R, Hacker M, Mitterhauser M, Wadsak W (2015) Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [11C]ME@HAPTHI EJNMMI Res, 5 (1)
• Dold M, Fugger G, Aigner M, Lanzenberger R, Kasper S (2015) Dose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials Schizophr Res, 166 (1-3): 187-193
• Hoflich A, Hahn A, Kublbock M, Kranz G, Vanicek T, Windischberger C, Saria A, Kasper S, Winkler D, Lanzenberger R (2015) Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia Int J Neuropsychopharmacol,
• Seiger R, Hahn A, Hummer A, Kranz GS, Ganger S, Küblböck M, Kraus C, Sladky R, Kasper S, Windischberger C, Lanzenberger R (2015) Voxel-based morphometry at ultra-high fields. A comparison of 7 T and 3 T MRI data Neuroimage, 113: 207-216
• Fuchs I, Ansorge U, Huber-Huber C, Höflich A, Lanzenberger R (2015) S-ketamine influences strategic allocation of attention but not exogenous capture of attention Conscious Cogn,
• Haeusler D, Kuntner C, Nics L, Savli M, Zeilinger M, Wanek T, Karagiannis P, Lanzenberger R, Langer O, Shanab K, Spreitzer H, Wadsak W, Hacker M, Mitterhauser M (2015) [18F]FE@SUPPY: a suitable PET tracer for the adenosine A3 receptor? An in vivo study in rodents Eur J Nucl Med Mol Imaging,
• Baldinger P, Kraus C, Rami-Mark C, Gryglewski G, Kranz G, Haeusler D, Hahn A, Spies M, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R (2015) Interaction between 5-HTTLPR and 5-HT1B genotype status enhances cerebral 5-HT1A receptor binding Neuroimage, 111: 505-512
• Sladky R, Spies M, Hoffmann A, Kranz G, Hummer A, Gryglewski G, Lanzenberger R, Windischberger C, Kasper S (2015) (S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling Neuroimage, 113: 207-216
• Hahn A, Kranz G, Sladky R, Ganger S, Windischberger C, Kasper S, Lanzenberger R (2015) Individual diversity of functional brain network economy Brain Connect, 5 (3): 156-165

• Kranz G, Wadsak W, Kaufmann U, Savli M, Baldinger P, Gryglewski G, Haeusler D, Spies M, Mitterhauser M, Kasper S, Lanzenberger R (2014) High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People Biol Psychiatry,
• Kranz G, Hahn A, Kaufmann U, Kublbock M, Hummer A, Ganger S, Seiger R, Winkler D, Swaab D, Windischberger C, Kasper S, Lanzenberger R (2014) White Matter Microstructure in Transsexuals and Controls Investigated by Diffusion Tensor Imaging J Neurosci, 34 (46): 15466-15475
• Vanicek T, Spies M, Rami-Mark C, Savli M, Höflich A, Kranz G, Hahn A, Kutzelnigg A, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Volkow N, Kasper S, Lanzenberger R (2014) The Norepinephrine Transporter in Attention-Deficit/Hyperactivity Disorder Investigated With Positron Emission Tomography JAMA Psychiatry, 71 (12): 1340-1349
• Seidel E, Pfabigan D, Hahn A, Sladky R, Grahl A, Paul K, Kraus C, Küblböck M, Kranz G, Hummer A, Lanzenberger R, Windischberger C, Lamm C (2014) Uncertainty during pain anticipation: The adaptive value of preparatory processes Human Brain Mapping,
• Hahn A, Kranz G, Küblböck M, Kaufmann U, Ganger S, Hummer A, Seiger R, Spies M, Winkler D, Kasper S, Windischberger C, Swaab D, Lanzenberger R (2014) Structural Connectivity Networks of Transgender People Cereb. Cortex,
• Kraus C, Baldinger P, Rami-Mark C, Gryglewski G, Kranz G, Haeusler D, Hahn A, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R (2014) Exploring the Impact of BDNF Val66Met Genotype on Serotonin Transporter and Serotonin-1A Receptor Binding PLoS One, 9 (9): e106810
• Kranz G, Hahn A, Baldinger P, Haeusler D, Philippe C, Kaufmann U, Wadsak W, Savli M, Hoeflich A, Kraus C, Vanicek T, Mitterhauser M, Kasper S, Lanzenberger R (2014) Cerebral serotonin transporter asymmetry in females, males and male-to-female transsexuals measured by PET in vivo Brain Struct Funct, 219 (1): 171-183
• Kraus C, Ganger S, Losak J, Hahn A, Savli M, Kranz G, Baldinger P, Windischberger C, Kasper S, Lanzenberger R (2014) Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake Neuroimage, 84: 236-244
• Baldinger P, Kranz G, Haeusler D, Savli M, Spies M, Philippe C, Hahn A, Höflich A, Wadsak W, Mitterhauser M, Lanzenberger R, Kasper S (2014) Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET Neuroimage, 88: 252-262
• Hahn A, Haeusler D, Kraus C, Höflich A, Kranz G, Baldinger P, Savli M, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R (2014) Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression Human Brain Mapping, 35 (8): 3857-3866
• Comasco E, Hahn A, Ganger S, Gingnell M, Bannbers E, Oreland L, Wikström J, Epperson C, Lanzenberger R, Sundström-Poromaa I (2014) Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder Human Brain Mapping, 35 (9): 4450-4458
• Scharinger C, Rabl U, Kasess C, Meyer B, Hofmaier T, Diers K, Bartova L, Pail G, Huf W, Uzelac Z, Hartinger B, Kalcher K, Perkmann T, Haslacher H, Meyer-Lindenberg A, Kasper S, Freissmuth M, Windischberger C, Willeit M, Lanzenberger R, Esterbauer H ,Brocke B, Moser E, Sitte H, Pezawas L (2014) Platelet Serotonin Transporter Function Predicts Default-Mode Network Activity PLoS One, 9 (3): e92543
• Fabbri C, Marsano A, Albani D, Chierchia A, Calati R, Drago A, Crisafulli C, Calabrò M, Kasper S, Lanzenberger R, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A (2014) PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway Pharmacogenomics J, 14 (5): 463-472
• Pfabigan D, Seidel E, Sladky R, Hahn A, Paul K, Grahl A, Küblböck M, Kraus C, Hummer A, Kranz G, Windischberger C, Lanzenberger R, Lamm C (2014) P300 amplitude variation is related to ventral striatum BOLD response during gain and loss anticipation: An EEG and fMRI experiment Neuroimage, 96: 12-21
• Gryglewski G, Lanzenberger R, Kranz G, Cumming P (2014) Meta-analysis of molecular imaging of serotonin transporters in major depression J Cereb Blood Flow Metab, 34 (7): 1096-1103
• Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R (2014) Neurotransmitters and Electroconvulsive Therapy J ECT, 30 (2): 116-121
• Kranz G, Rami-Mark C, Kaufmann U, Baldinger P, Hahn A, Höflich A, Savli M, Stein P, Wadsak W, Mitterhauser M, Winkler D, Lanzenberger R, Kasper S (2014) Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-11C]WAY-100635 Psychoneuroendocrinology, 45: 1-10
• Stein P, Baldinger P, Kaufmann U, Christina R, Hahn A, Höflich A, Kranz G, Savli M, Wadsak W, Mitterhauser M, Winkler D, Kasper S, Lanzenberger R (2014) Relation of progesterone and DHEAS serum levels to 5-HT1A receptor binding potential in pre- and postmenopausal women Psychoneuroendocrinology, 46: 52-63
• Winkler D, Pjrek E, Lanzenberger R, Baldinger P, Eitel D, Kasper S, Frey R (2014) Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy J Psychiatr Res, 57: 96-100
• Kasper S, Kranz G, Lanzenberger R (2014) Testosterone, Neural Circuits, and Male Depression Biol Psychiatry, 76 (4): 272-273

• Kasper S, Gryglewski G, Lanzenberger R (2014) Imaging brain circuits in anxiety disorders Lancet Psychiatry, 1 (4): 251-252
• Toffoletto S, Lanzenberger R, Gingnell M, Sundström-Poromaa I, Comasco E (2014) Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: A systematic review Psychoneuroendocrinology, 50: 28-52

• Spindelegger C, Willeit M, Praschak-Rieder N, Lanzenberger R, Kasper S (2014) Neuroimaging in seasons and winter depression. In: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, den Boer JA (eds.), PET and SPECT in Psychiatry. Vol. 1. Berlin-Heidelberg-New York: Springer Verlag: pp. 209-222

• Sladky R, Baldinger P, Kranz G, Tröstl J, Höflich A, Lanzenberger R, Moser E, Windischberger C (2013) High-resolution functional MRI of the human amygdala at 7T Eur J Radiol, 82 (5): 728-733
• Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R (2013) Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET Mol Psychiatry, 18 (1): 93-100
• Derntl B, Schopf V, Kollndorfer K, Lanzenberger R (2013) Menstrual Cycle Phase and Duration of Oral Contraception Intake Affect Olfactory Perception Chem Senses, 38 (1): 67-75
• Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R (2013) Impact of electroconvulsive therapy on 5-HT1A receptor binding in major depression Mol Psychiatry, 18 (1): 1-1
• Kalcher K, Boubela R, Huf W, Biswal B, Baldinger P, Sailer U, Filzmoser P, Kasper S, Lamm C, Lanzenberger R, Moser E, Windischberger C (2013) RESCALE: Voxel-specific task-fMRI scaling using resting state fluctuation amplitude Neuroimage, 70: 80-88
• Hahn A, Nics L, Baldinger P, Wadsak W, Savli M, Kraus C, Birkfellner W, Ungersboeck J, Haeusler D, Mitterhauser M, Karanikas G, Kasper S, Frey R, Lanzenberger R (2013) Application of image-derived and venous input functions in major depression using [carbonyl-11C]WAY-100635 Nucl Med Biol, 40 (3): 371-377
• Höflich A, Savli M, Comasco E, Moser U, Novak K, Kasper S, Lanzenberger R (2013) Neuropsychiatric deep brain stimulation for translational neuroimaging Neuroimage, 79: 30-41
• Hahn A, Kranz G, Seidel E, Sladky R, Kraus C, Küblböck M, Pfabigan D, Hummer A, Grahl A, Ganger S, Windischberger C, Lamm C, Lanzenberger R (2013) Comparing neural response to painful electrical stimulation with functional MRI at 3 and 7T Neuroimage, 82: 336-343
• Baldinger P, Hahn A, Mitterhauser M, Kranz G, Friedl M, Wadsak W, Kraus C, Ungersböck J, Hartmann A, Giegling I, Rujescu D, Kasper S, Lanzenberger R (2013) Impact of COMT genotype on serotonin-1A receptor binding investigated with PET Brain Struct Funct, 219 (6): 2017-2028
• Rami-Mark C, Ungersboeck J, Haeusler D, Nics L, Philippe C, Mitterhauser M, Willeit M, Lanzenberger R, Karanikas G, Wadsak W (2013) Reliable set-up for in-loop 11C-carboxylations using Grignard reactions for the preparation of [carbonyl-11C]WAY-100635 and [11C]-(+)-PHNO Appl Radiat Isot, 82: 75-80
• Philippe C, Nics L, Zeilinger M, Schirmer E, Spreitzer H, Karanikas G, Lanzenberger R, Viernstein H, Wadsak W, Mitterhauser M. (2013) Preparation and First Preclinical Evaluation of [18F]FE@SNAP: A Potential PET Tracer for the Melanin Concentrating Hormone Receptor 1 (MCHR1) Sci Pharm, 81 (3): 625-639
• Sladky R, Hoflich A, Kublbock M, Kraus C, Baldinger P, Moser E, Lanzenberger R, Windischberger C (2013) Disrupted Effective Connectivity Between the Amygdala and Orbitofrontal Cortex in Social Anxiety Disorder During Emotion Discrimination Revealed by Dynamic Causal Modeling for fMRI Cereb. Cortex,

• Baldinger P, Kranz G, Höflich A, Savli M, Stein P, Lanzenberger R, Kasper S (2013) Hormonersatztherapie und deren Wirkung auf Psyche und Gehirn Nervenarzt, 84 (1): 14-19
• Höfer P, Lanzenberger R, Kasper S (2013) Testosterone in the brain: Neuroimaging findings and the potential role for neuropsychopharmacology Eur Neuropsychopharmacol, 23 (2): 79-88
• Dold M, Aigner M, Lanzenberger R, Kasper S (2013) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials Int. J. Neuropsychopharmacol., 16 (3): 557-574
• Vyas NS, Patel NH, Herscovitch P, Puri BK, Lanzenberger R (2013) Recent developments in neurochemical imaging in schizophrenia: an update. Curr Med Chem, : 351-6

• Spindelegger C, Stein P, Wadsak W, Fink M, Mitterhauser M, Moser U, Savli M, Mien L, Akimova E, Hahn A, Willeit M, Kletter K, Kasper S, Lanzenberger R (2012) Light-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain World J Biol Psychiat, 13 (6): 413-422
• Hahn A, Wadsak W, Windischberger C, Baldinger P, Hoflich A, Losak J, Nics L, Philippe C, Kranz G, Kraus C, Mitterhauser M, Karanikas G, Kasper S, Lanzenberger R (2012) Differential modulation of the default mode network via serotonin-1A receptors PNAS, 109 (7): 2619-2624
• Hahn A, Nics L, Baldinger P, Ungersböck J, Dolliner P, Frey R, Birkfellner W, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R (2012) Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling Neuroimage, 62 (1): 199-206
• Ungersboeck J, Richter S, Collier L, Mitterhauser M, Karanikas G, Lanzenberger R, Dudczak R, Wadsak W (2012) Radiolabeling of [18F]altanserin - a microfluidic approach Nucl Med Biol, 39 (7): 1087-1092
• Kranz G, Hahn A, Savli M, Lanzenberger R (2012) Challenges in the differentiation of midbrain raphe nuclei in neuroimaging research PNAS, 109 (29): E2000
• Riederer F, Marti M, Luechinger R, Lanzenberger R, von Meyenburg J, Gantenbein A, Pirrotta R, Gaul C, Kollias S, Sándor P (2012) Grey matter changes associated with medication-overuse headache: Correlations with disease related disability and anxiety World J Biol Psychiat, 13 (7): 517-525
• Savli M, Bauer A, Mitterhauser M, Ding Y, Hahn A, Kroll T, Neumeister A, Haeusler D, Ungersboeck J, Henry S, Isfahani S, Rattay F, Wadsak W, Kasper S, Lanzenberger R (2012) Normative database of the serotonergic system in healthy subjects using multi-tracer PET Neuroimage, 63 (1): 447-459
• Lanzenberger R, Kranz G, Haeusler D, Akimova E, Savli M, Hahn A, Mitterhauser M, Spindelegger C, Philippe C, Fink M, Wadsak W, Karanikas G, Kasper S (2012) Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas Neuroimage, 63 (2): 874-881
• Kraus C, Hahn A, Savli M, Kranz G, Baldinger P, Höflich A, Spindelegger C, Ungersboeck J, Haeusler D, Mitterhauser M, Windischberger C, Wadsak W, Kasper S, Lanzenberger R (2012) Serotonin-1A receptor binding is positively associated with gray matter volume — A multimodal neuroimaging study combining PET and structural MRI Neuroimage, 63 (3): 1091-1098
• Philippe C, Ungersboeck J, Schirmer E, Zdravkovic M, Nics L, Zeilinger M, Shanab K, Lanzenberger R, Karanikas G, Spreitzer H, Viernstein H, Mitterhauser M, Wadsak W (2012) [¹⁸F]FE@SNAP-A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): microfluidic and vessel-based approaches. Bioorg Med Chem, : 5936–5940
• Philippe C, Schirmer E, Mitterhauser M, Shanab K, Lanzenberger R, Karanikas G, Spreitzer H, Viernstein H, Wadsak W (2012) Radiosynthesis of [11C]SNAP-7941—the first PET-tracer for the melanin concentrating hormone receptor 1 (MCHR1) Appl Radiat Isot, 70 (10): 2287-2294
• Ungersboeck J, Philippe C, Haeusler D, Mitterhauser M, Lanzenberger R, Dudczak R, Wadsak W (2012) Optimization of [11C]DASB-synthesis: Vessel-based and flow-through microreactor methods Appl Radiat Isot, 70 (11): 2615-2620
• Nics L, Hahn A, Zeilinger M, Vraka C, Ungersboeck J, Haeusler D, Hartmann S, Wagner K, Lanzenberger R, Wadsak W, Mitterhauser M (2012) Quantification of the radio-metabolites of the serotonin-1A receptor radioligand [carbonyl-11C]WAY-100635 in human plasma: An HPLC-assay which enables measurement of two patients in parallel Appl Radiat Isot, 70 (12): 2730-2736
• Sladky R, Höflich A, Atanelov J, Kraus C, Baldinger P, Moser E, Lanzenberger R, Windischberger C (2012) Increased Neural Habituation in the Amygdala and Orbitofrontal Cortex in Social Anxiety Disorder Revealed by fMRI PLoS One, 7 (11): e50050

• Stein P, Lanzenberger R, Kasper S, Aigner M (2012) Psychiatrische Manifestation einer milden Form der limbischen Encephalitis. Journal für Neurologie, Neurochirurgie und Psychiatrie, 13(1): 31-34
• Saulin A, Savli M, Lanzenberger R (2012) Serotonin and molecular neuroimaging in humans using PET Amino Acids, 42 (6): 2039-2057
• Höflich A, Baldinger P, Savli M, Lanzenberger R, Kasper S (2012) Imaging treatment effects in depression Rev Neurosci, 23 (3)

• Schöpf V, Windischberger C, Robinson S, Kasess C, Fischmeister F, Lanzenberger R, Albrecht J, Kleemann A, Kopietz R, Wiesmann M, Moser E (2011) Model-free fMRI group analysis using FENICA Neuroimage, 55 (1): 185-193
• Hahn A, Stein P, Windischberger C, Weissenbacher A, Spindelegger C, Moser E, Kasper S, Lanzenberger R (2011) Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder Neuroimage, 56 (3): 881-889
• Ungersboeck J, Philippe C, Mien L, Haeusler D, Shanab K, Lanzenberger R, Spreitzer H, Keppler B, Dudczak R, Kletter K, Mitterhauser M, Wadsak W (2011) Microfluidic preparation of [18F]FE@SUPPY and [18F]FE@SUPPY:2 - comparison with conventional radiosyntheses Nucl Med Biol, 38 (3): 427-434
• Lanzenberger R, Mitterhauser M, Kranz G, Spindelegger C, Wadsak W, Stein P, Moser U, Savli M, Kletter K, Kasper S (2011) Progesterone Level Predicts Serotonin-1A Receptor Binding in the Male Human Brain Neuroendocrinology, 94 (1): 84-88

• Fink M, Moser U, Akimova E, Savli M, Lanzenberger R, Kasper S (2011) ) Multimodale Bildgebung bei einer organischen depressiven Störung mittels fMRT und PET Journal für Neurologie, Neurochirurgie und Psychiatrie, 12(2): 180-182
• Dold M, Aigner M, Lanzenberger R, Kasper S (2011) Effektivität einer Augmentationstherapie mit Antipsychotika bei therapieresistenten Zwangsstörungen – eine Metaanalyse doppelblinder, randomisierter, placebokontrollierter Studien Fortschr Neurol Psychiatr, 79 (08): 453-466

• Witte A, Savli M, Holik A, Kasper S, Lanzenberger R (2010) Regional sex differences in grey matter volume are associated with sex hormones in the young adult human brain Neuroimage, 49 (2): 1205-1212
• Windischberger C, Lanzenberger R, Holik A, Spindelegger C, Stein P, Moser U, Gerstl F, Fink M, Moser E, Kasper S (2010) Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: A randomized cross-over study Neuroimage, 49 (2): 1161-1170
• Moser U, Wadsak W, Spindelegger C, Mitterhauser M, Mien L, Bieglmayer C, Kletter K, Kasper S, Lanzenberger R (2010) Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women Neurosci Lett, 476 (3): 161-165
• Haeusler D, Nics L, Viernstein H, Wagner K, Dudcz L, Mien L, Ungersboeck J, Lanzenberger R, Shanab K, Sindelar K, Vieak R, Kletter K, Wadsak W, Mitterhauser M (2010) [18F]FE@SUPPY and [18F]FE@SUPPY:2 — metabolic considerations Nucl Med Biol, 37 (4): 421-426
• Lanzenberger R, Wadsak W, Spindelegger C, Mitterhauser M, Akimova E, Mien L, Fink M, Moser U, Savli M, Kranz G, Hahn A, Kletter K, Kasper S (2010) Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions Int J Neuropsychopharmacol, 13 (9): 1129-1143
• Schöpf V, Windischberger C, Kasess C, Lanzenberger R, Moser E (2010) Group ICA of resting-state data: a comparison MAGMA, 23 (5-6): 317-325
• Schöpf V, Kasess C, Lanzenberger R, Fischmeister F, Windischberger C, Moser E (2010) Fully exploratory network ICA (FENICA) on resting-state fMRI data J. Neurosci. Methods, 192 (2): 207-213
• Assem-Hilger E, Lanzenberger R, Savli M, Wadsak W, Mitterhauser M, Mien L, Stogmann E, Baumgartner C, Kletter K, Asenbaum S (2010) Central serotonin 1A receptor binding in temporal lobe epilepsy: A [carbonyl-11C]WAY-100635 PET study Epilepsy Behav, 19 (3): 467-473
• Hahn A, Lanzenberger R, Wadsak W, Spindelegger C, Moser U, Mien L, Mitterhauser M, Kasper S (2010) Escitalopram Enhances the Association of Serotonin-1A Autoreceptors to Heteroreceptors in Anxiety Disorders J Neurosci, 30 (43): 14482-14489

• Kranz G, Kasper S, Lanzenberger R (2010) Reward and the serotonergic system Neuroscience, 166 (4): 1023-1035

• Haeusler D, Mitterhauser M, Mien LK, Shanab K, Lanzenberger R, Schirmer E, Ungersboeck J, Nics L, Spreitzer H, Viernstein H, Dudczak R, Kletter K, Wadsak W. (2009) Radiosynthesis of a novel potential adenosine A3 receptor ligand, 5-ethyl 2,4-diethyl-3-((2-[18F]fluoroethyl)sulfanylcarbonyl)-6-phenylpyridine-5-carboxylate ([18F]FE@SUPPY:2) Radiochim Acta, 97: 753-8
• Spindelegger C, Lanzenberger R, Wadsak W, Mien L, Stein P, Mitterhauser M, Moser U, Holik A, Pezawas L, Kletter K, Kasper S (2009) Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders Mol Psychiatry, 14 (11): 1040-1050
• Witte A, Flöel A, Stein P, Savli M, Mien L, Wadsak W, Spindelegger C, Moser U, Fink M, Hahn A, Mitterhauser M, Kletter K, Kasper S, Lanzenberger R (2009) Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects Human Brain Mapping, 30 (8): 2558-2570
• Fink M, Wadsak W, Savli M, Stein P, Moser U, Hahn A, Mien L, Kletter K, Mitterhauser M, Kasper S, Lanzenberger R (2009) Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET Neuroimage, 45 (2): 598-605
• Haeusler D, Mien L, Nics L, Ungersboeck J, Philippe C, Lanzenberger R, Kletter K, Dudczak R, Mitterhauser M, Wadsak W (2009) Simple and rapid preparation of [11C]DASB with high quality and reliability for routine applications Appl Radiat Isot, 67 (9): 1654-1660
• Weissenbacher A, Kasess C, Gerstl F, Lanzenberger R, Moser E, Windischberger C (2009) Correlations and anticorrelations in resting-state functional connectivity MRI: A quantitative comparison of preprocessing strategies Neuroimage, 47 (4): 1408-1416

• Fink M, Akimova E, Spindelegger C, Hahn A, Lanzenberger R, Kasper S. (2009) Social anxiety disorder: epidemiology, biology and treatment. Psychiatr Danub., 21(4): 533-42
• Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R (2009) Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram Int Clin Psychopharmacol, 24 (3): 119-125
• Akimova E, Lanzenberger R, Kasper S (2009) The Serotonin-1A Receptor in Anxiety Disorders Biol Psychiatry, 66 (7): 627-635

• Stein P, Savli M, Wadsak W, Mitterhauser M, Fink M, Spindelegger C, Mien L, Moser U, Dudczak R, Kletter K, Kasper S, Lanzenberger R (2008) The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635 Eur J Nucl Med Mol Imaging, 35 (12): 2159-2168
• Wadsak W, Mien LK, Shanab K, Ettlinger DE, Haeusler D, Sindelar K, Lanzenberger R, Spreitzer H, Viernstein H, Keppler BK, Dudczak R, Kletter K, Mitterhauser M. (2008) Preparation and first evaluation of [(18)F]FE@SUPPY: a new PET tracer for the adenosine A(3) receptor. Nucl Med and Biol, 35(1): 61-6
• Windischberger C, Cunnington R, Lamm C, Lanzenberger R, Langenberger H, Deecke L, Bauer H, Moser E (2008) Time-resolved analysis of fMRI signal changes using Brain Activation Movies J. Neurosci. Methods, 169 (1): 222-230
• Kasess C, Windischberger C, Cunnington R, Lanzenberger R, Pezawas L, Moser E (2008) The suppressive influence of SMA on M1 in motor imagery revealed by fMRI and dynamic causal modeling Neuroimage, 40 (2): 828-837
• Gerstl F, Windischberger C, Mitterhauser M, Wadsak W, Holik A, Kletter K, Moser E, Kasper S, Lanzenberger R (2008) Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET Neuroimage, 41 (2): 204-211
• Riederer F, Lanzenberger R, Kaya M, Prayer D, Serles W, Baumgartner C (2008) Network atrophy in temporal lobe epilepsy: A voxel-based morphometry study Neurology, 71 (6): 419-425

• Wadsak W, Mien LK, Ettlinger DE, Feitscher S, Lanzenberger R, Marton J, Dudczak R, Kletter K, Mitterhauser M (2007) Preparation and radiosynthesis of [18F]FE@CFN (2-[18F]fluoroethyl 4-[N-(1- oxopropyl)-N-phenylamino]-1-(2-phenylethyl)-4-piperidinecarboxylate): a potential µ- opioid receptor imaging agent. Radiochim Acta, 95: 33-8
• Wadsak W, Mien LK, Ettlinger DE, Lanzenberger R, Haeusler D, Dudczak R, Kletter K, Mitterhauser M (2007) Simple and fully automated preparation of [carbonyl-11C]WAY-100635. Radiochim Acta, 95: 417-22
• Lanzenberger R, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Kletter K, Kasper S, Tauscher J. (2007) Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder. Biol Psychiatry, 61(9): 1081-9
• Mitterhauser M, Toegel S, Wadsak W, Lanzenberger R, Mien LK, Kuntner C, Wanek T, Eidherr H, Ettlinger DE, Viernstein H, Kluger R, Dudczak R, Kletter K. (2007) Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP Nucl Med and Biol, 34(4): 391-7

• Bauer M, Langer O, Dal-Bianco P, Karch R, Brunner M, Abrahim A, Lanzenberger R, Hofmann A, Joukhadar C, Carminati P, Ghirardi O, Piovesan P, Forloni G, Corrado ME, Lods N, Dudczak R, Auff E, Kletter K (2006) A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease. Clin Pharmacol Ther, 80(3): 216-27

• Robinson S, Hoheisel B, Windischberger C, Habel U, Lanzenberger R, Moser E (2005) FMRI of the Emotions: Towards an Improved Understanding of Amygdala Function CURR MED IMAGING REV, 1(2): 115-129
• Geissler A, Lanzenberger R, Barth M, Tahamtan AR, Milakara D, Gartus A, Beisteiner R. (2005) Influence of fMRI smoothing procedures on replicability of fine scale motor localization. Neuroimage, 24(2): 323-31
• Lanzenberger R, Wiest G, Geissler A, Barth M, Ringl H, Wöber C, Gartus A, Baumgartner C, Beisteiner R. (2005) FMRI reveals functional cortex in a case of inconclusive Wada testing Clin Neurol Neurosurg, 107(2): 147-51
• Roessler K, Donat M, Lanzenberger R, Novak K, Geissler A, Gartus A, Tahamtan AR, Milakara D, Czech T, Barth M, Knosp E, Beisteiner R. (2005) Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome. J Neurol Neurosurg Psychiatry, 76(8): 1152-7

• Beisteiner R, Gartus A, Erdler M, Mayer D, Lanzenberger R, Deecke L. (2004) Magnetoencephalography indicates finger motor somatotopy Eur J Neurosci, 19(2): 465-72

• Lanzenberger R, Beisteiner R, Prayer D. (2002) Discussion of the Brain Atlas for Functional Imaging (BAFI), W.L. Nowinski, A. Thirunavuukarasuu, D.N. Kennedy Eur J Radiol, 41(3): 255-6

• Beisteiner R, Windischberger C, Lanzenberger R, Edward V, Cunnington R, Erdler M, Gartus A, Streibl B, Moser E, Deecke L. (2001) Finger somatotopy in human motor cortex. Neuroimage, 6 Pt 1 : 1016-26
• Erdler M, Windischberger C, Lanzenberger R, Edward V, Gartus A, Deecke L, Beisteiner R. (2001) Dissociation of supplementary motor area and primary motor cortex in human subjects when comparing index and little finger movements with functional magnetic resonance imaging. Neurosci Lett, 313(1-2): 5-8

• Beisteiner R, Lanzenberger R, Novak K, Edward V, Windischberger C, Erdler M, Cunnington R, Gartus A, Streibl B, Moser E, Czech T, Deecke L. (2000) Improvement of presurgical patient evaluation by generation of functional magnetic resonance risk maps. Neurosci Lett, 290(1): 13-6
• Edward V, Windischberger C, Cunnington R, Erdler M, Lanzenberger R, Mayer D, Endl W, Beisteiner R. (2000) Quantification of fMRI artifact reduction by a novel plaster cast head holder. Human Brain Mapping, 11(3): 207-13